Palmar plantar erythrodysesthesia physical examination: Difference between revisions
Mchitsazan (talk | contribs) Tags: Replaced Visual edit |
Mchitsazan (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{{Palmar plantar erythrodysesthesia}} | {{Palmar plantar erythrodysesthesia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{MC}} | ||
==Overview== | ==Overview== |
Revision as of 17:12, 2 July 2019
Palmar plantar erythrodysesthesia Microchapters |
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
---|
Diagnosis |
Treatment |
Palmar plantar erythrodysesthesia physical examination On the Web |
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia physical examination |
FDA on Palmar plantar erythrodysesthesia physical examination |
CDC on Palmar plantar erythrodysesthesia physical examination |
Palmar plantar erythrodysesthesia physical examination in the news |
Blogs on Palmar plantar erythrodysesthesia physical examination |
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
Risk calculators and risk factors for Palmar plantar erythrodysesthesia physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]
Overview
Determination of toxicity grading of PPE requires both visual assessment and patient description of symptoms.
Physical Examination
Determination of toxicity grading of PPE requires both visual assessment and patient description of symptoms.
References